PhRMA Asks FDA To Be More Straightforward On Safeguards It Wants To Fight Drug Risks
We recommend:
Main Category: Regulatory Affairs / Drug Approvals
Also Included In: Pharma Industry / Biotech Industry ; Primary Care / General Practice
e-mail to a champion pressman favorable sight / spell opinions
The pharmaceutic diligence deal radical PhRMA aforementioned Monday that the Food and Drug Administration should do a meliorate job of explaining extra safeguards it mandates against sealed drugs when it issues warnings, Reuters reports. “That testimonial is one of gobs expected this hebdomad at a populace merging on the FDA’s jeopardy rating and extenuation strategies, or REMS, a set of tools to protect consumers from drugs with potentially good position effects.” The FDA requires drugmakers to supply consumers entropy on potency dose risks by publication medicine guides and/or education of physicians who dictate sure drugs.
“The tools are among new FDA powers included in a 2007 law. Since the law took impression in 2008, the FDA has mandated risk-minimizing strategies for more than 120 drugs. … PhRMA aforementioned that the FDA should apply the medicine guides extraneous of the REMS model, something the office has through in the by” (Lentz, 7/26).
This info was reprinted from kaiserhealthnews.org with variety license from the Henry J. Kaiser Family Foundation. You can panorama the total Kaiser Daily Health Policy Report, hunt the archives and signal up for netmail bringing at kaiserhealthnews.org .
© Henry J. Kaiser Family Foundation. All rights reserved.
All opinions are moderated ahead existence added.
Please bill that we issue your figure , but we do not release your e-mail accost. It is lonesome put-upon to let you cognize when your substance is promulgated. We do not use it for any former use. Please see our privateness insurance for more entropy.
If you compose most particular medications or operations, delight do not gens wellness maintenance professionals by diagnose.
For any corrections of actual info, or to impinging the editors delight use our feedback mannequin .
Please beam any aesculapian intelligence or wellness word crush releases to:
Personalize Your Homepage Weekly Newsletters Daily News Alerts
Hemoheart Pneumococcal Disease All ‘What Is…’ Articles
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us
Regulatory Affairs Forum Discuss issues relating to regulative affairs / dose approvals in our new assembly.
Latest News For Regulatory Affairs / Drug Approvals
ACT Files Documentation With FDA For Clinical Trials Using ES Cells To Treat Eye Disease
Abbott’s SIMCOR(R) (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths
Mapping NTDs Is Critical For Controlling, Treating Diseases
View more intelligence…
These are the well-nigh translate articles from this intelligence class for the close 6 months:
FDA Approves First Generic Versions Of Two Drugs For The Treatment Of Hypertension
On April 6, the U.S. Food and Drug Administration sanctioned the get-go generic versions of two drugs ill-used for the intervention of hypertension. Losartan k tablets and losartan k and esidrix tablets (a…
Clinical Benefit Of Multiple Sclerosis Drug Discovered
FDA Approves First Generic Blood Thinner Enoxaparin Sodium Injection (Lovenox)
Concerns Raised About Lady Gaga Inspired Circle Lenses
Novo Nordisk Receives US Approval For Victoza® (liraglutide) For The Treatment Of Type 2 Diabetes
Follow Our News On Twitter:
Get the up-to-the-minute tidings for this family delivered full-strength to your Twitter chronicle. Simply pawl the tie-in downstairs and prime the ‘espouse’ alternative.
The right victuals can avail you get the nigh out of your exercising. Knowing when to eat and what to eat testament create bettor results when you example.
more videos are uncommitted in our wellness videos department .
Today besellers:
